Article
Receiving a Pathogenic Variant in a Population Breast Cancer Screening Trial: A Mixed Method Study.
Public health genomics - 1 Jan 2024
Riddle Leslie, James Jennifer Elyse, Naeim Arash, Madlensky Lisa, Brain Susie, DeRosa Diana, Eklund Martin, Fiscalini Allison Stover, Heditsian Diane, Koenig Barbara, Ross Katherine, Sabacan Leah P, Tong Barry, Wenger Neil, Joseph Galen
Abstract excerpt
INTRODUCTION: Risk-based breast cancer screening aims to address persistent high morbidity and mortality. This study examined the experience of participants in the Women Informed to Screen Depending on Measures of Risk (WISDOM) trial who received a pathogenic variant in one of nine high or moderate penetrance breast cancer genes. METHODS: Participants completed a brief survey (n = 181) immediately following the...
Topics
- Humans
- Female
- Breast Neoplasms
- Middle Aged
- Early Detection of Cancer
- Genetic Testing
- Adult
- Genetic Predisposition to Disease
- Surveys and Questionnaires
- Aged
- Genetic Counseling